×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Midatech Pharma Rallies On Positive MTX102 Results
AOL.com
Midatech Pharma PLC-ADR (NASDAQ: MTP ) shares were trading higher Friday after the company announced positive results from a first-in-human study of its...
2 weeks ago
Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024
Yahoo Finance
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected...
3 months ago
Teetering on the edge, Midatech plots pivot beyond drug delivery platform with Bioasis buyout
Fierce Pharma
"By combining the two groups to create Biodexa Pharmaceuticals, we have the opportunity to reposition the enlarged group as an emerging biotech...
16 months ago
J&J expands it long-acting injectables partnership with Midatech
Drug Delivery Business
Midatech Pharma (Nasdaq:MTP) announced today that it extended its R&D collaboration with Johnson & Johnson's Janssen Pharmaceuticals.
25 months ago
Why Is Midatech Pharma (BDRX) Stock Up 64% Today?
InvestorPlace
Midatech Pharma (BDRX) stock is rocketing higher on Tuesday after the pharmaceutical company announced a new research program.
13 months ago
Midatech Pharma PLC Announces Results of General Meeting
Yahoo Finance
Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of...
13 months ago
Midatech Pharma US, Inc. Announces Corporate Name Change To Fortovia Therapeutics And Appointment Of New ...
PR Newswire
Midatech Pharma US, Inc. Announces Corporate Name Change To Fortovia Therapeutics And Appointment Of New CEO And CFO ... Midatech Pharma US, Inc.
58 months ago
Midatech to begin dose escalation Phase I study of MTX-110
Clinical Trials Arena
Midatech has announced plans to continue with planned dose escalation in the Phase I study of MTX-110 in recurrent glioblastoma patients.
15 months ago
Investors kibosh Midatech merger, triggering scramble for cash
Fierce Pharma
After striking a deal to buy Bioasis, Midatech put its plans to a vote—only for investors to shoot down the idea and leave it with weeks to...
15 months ago
Midatech Pharma awarded EU grant funding to support training and research into glycan based multivalent ...
Drug Target Review
Commenting on the grant award, Dr Jim Philips, CEO of Midatech Pharma, said: “I am pleased that Midatech and its consortium partners have been...
112 months ago